Addictive Research

Addictive Research 20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments? By Kerry Grens Related Articles 1 When the drug was removed, the enzyme's activity spiked, which the authors interpret as a cellular withdrawal from dependency: "This phenomenon can be likened to the abstinence syndrome in animals." "You're profoundly altering the nature of nerve cells." -E

kerry grens
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

By Kerry Grens

1 When the drug was removed, the enzyme's activity spiked, which the authors interpret as a cellular withdrawal from dependency: "This phenomenon can be likened to the abstinence syndrome in animals."

It wasn't until more than a decade later, in the early 1990s, when Nestler, then at Yale University, and his group replicated the results in vivo and moved two steps downstream from adenylyl cyclase to the activation of CREB. They showed that a dose of morphine impairs the phosphorylation of CREB (a marker of CREB activation), but that activity returns to normal after a longer exposure to the drug.2 "Around the same time," Nestler recalls, "we were asking: The locus ceruleus is just a model system for the opiate system, but do other neurons respond?" He turned to the nucleus accumbens, a group of neurons that receive dopaminergic inputs from the ventral tegmental area, and which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo